全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 163517-61-1 | B-(3-Fluoro-2-Methylphenyl)-Boronic Acid;(3-Fluoro-2-Methyl-Phenyl)Boronic Acid;2-Methyl-3-Fluoro-Phenylboronic Acid;Fs000779 | C7H8BFO2 |
| 163517-62-2 | 5-Fluoro-2-methylphenylboronic acid;5-Fluoro-2-methylbenzeneboronic acid; (5-Fluoro-2-methylphenyl)boronic acid | C7H8BFO2 |
| 163520-33-0 | 4,5-Dihydro-5,5-diphenyl-3-isoxazolecarboxylic acid ethyl ester;AE-F 122006; HOE 122006; Isoxadifen ethyl ester | C18H17NO3 |
| 163521-08-2 | Vilazodone hydrochloride;5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide hydrochloride | C26H27N5O2.HCl |
| 163521-09-3 | 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochloride | C28H30N4O3.2(HCl) |
| 163521-11-7 | 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester | C28H30N4O3 |
| 163521-12-8 | Vilazodone;5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide | C26H27N5O2 |
| 163521-19-5 | 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid | C26H26N4O3 |
| 163521-20-8 | Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate | C15H18N2O3 |
| 163554-55-0 | 2-Methyl-2-Propanyl (1-Formylcyclobutyl)Carbamate;MFCD21604087;tert-Butyl (1-formylcyclobutyl)carbamate;tert-butyl 1-formylcyclobutylcarbamate | C10H17NO3 |
| 163556-04-5 | 3,5-Diformyl-1-indolizinecarboxylic acid methyl ester | C12H9NO4 |
| 163558-30-3 | Fmoc-S-sulfo-L-cysteine disodium salt;N-[(9H-fluoren-9-ylmethoxy)carbonyl]-S-sulfo-L-cysteine disodium salt | C18H15NNa2O7S2 |
| 163563-64-2 | 2-Chloro-6-phenylnicotinonitrile;2-Chloro-4-phenyl-3-pyridinecarbonitrile | C12H7ClN2 |
| 163596-56-3 | (E)-1-(3-Phenyl-2-propenyl)piperazine dihydrochloride | C13H18N2.2(HCl) |
| 163596-75-6 | 4-Bromo-3-nitrobenzaldehyde | C7H4BrNO3 |
| 163597-57-7 | 3-Cyano-4-isobutyloxythiobenzamide;3-Cyano-4-(2-methylpropoxy)benzenecarbothioamide | C12H14N2OS |
| 163619-04-3 | Fmoc-D-Trp(Boc)-OH;N-alpha-Fmoc-N(in)-Boc-D-tryptophan; N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-in-tert-butyl-oxycarbonyl-D-tryptophan | C31H30N2O6 |
| 163620-24-4 | 2-(1-Methylhydrazino)-5-(trifluoromethyl)pyridine | C7H8F3N3 |
| 163630-79-3 | 1'-[4-[1-(4-Fluorophenyl)-1H-indol-3-yl]butyl]-spiro[isobenzofuran-1(3H),4'-piperidine] (E)-2-butenedioate (1:1) | C30H31FN2O.C4H4O4 |
| 163655-37-6 | (3Z)-3-{[4-(Dimethylamino)-1-Naphthyl]Methylene}-1,3-Dihydro-2H-Indol-2-One;3-(4-Dime<wbr>thylamino<wbr>naphthale<wbr>n-1-ylmet<wbr>hylene)-1<wbr>,3-dihydr<wbr>oindol-2-<wbr>one;MAZ51;M1695_SIGMA | C21H18N2O |
| 163658-33-1 | (6-Ethylpyridin-2-yl)methanol | C8H11NO |
| 163679-35-4 | 2,5-Dioxo-1-Pyrrolidinyl 3,5-Diiodo-N-{[(2-Methyl-2-Propanyl)Oxy]Carbonyl}-L-Tyrosinate;Boc-3,5-diiodo-L-tyrosine hydroxysuccinimide ester;BOC-3,5-DIIODO-TYR-OSU;Boc-Tyr(3,5-I2)-OSu | C18H20I2N2O7 |
| 163680-77-1 | Pazufloxacin mesilate;Pazufloxaxin methanesulfonate; (3S)-10-(1-Aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid methanesulfonate | C16H15FN2O4.CH4O3S |
| 163685-38-9 | 1-[2-(2-Methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-2-propanol | C15H25NO3 |
| 163702-05-4 | (Perfluorobutoxy)ethane;1-Ethoxynonafluorobutane; CF 76; Cosmetic Fluid CF 76; Ethyl nonafluorobutyl ether; Ethyl perfluorobutyl ether; HFE 569mccc; HFE 569sf2; HFE 7200; Nonafluorobutyl ethyl ether; Novec 7200; Novec HFE 7200 | C6H5F9O |
| 163702-07-6 | Methyl nonafluorobutyl ether;Perfluorobutyl methyl ether; Methyl 1,1,2,2,3,3,4,4,4-nonafluorobutyl ether | C5H3F9O |
| 163702-08-7 | 1,1,2,3,3,3-Hexafluoro-1-methoxy-2-(trifluoromethyl)propane;2-(Difluoromethoxymethyl)-1,1,1,2,3,3,3-heptafluoropropane; Methyl nonafluoroisobutyl ether; Methyl perfluoroisobutyl ether; Perfluoroisobutyl methyl ether; i 7100 | C5H3F9O |
| 163704-47-0 | 2-Iodo-1,3-diisopropylbenzene | |
| 163706-06-7 | Cangrelor;AR-C 69931; N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-5'-adenylic acid anhydride with P,P'-(dichloromethylene)bis[phosphonic acid] | C17H25Cl2F3N5O12P3S2 |
| 163706-36-3 | Cangrelor tetrasodium;AR-C 69931MX | C17H21Cl2F3N5O12P3S2.Na4 |
| 163706-51-2 | 2-[(3,3,3-Trifluoropropyl)thio]adenosine | C13H16F3N5O4S |
| 163706-58-9 | N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]adenosine | C16H22F3N5O4S2 |
| 163706-61-4 | (Dichloromethylene)bis[phosphonic acid] mono(tributylamine) salt | C12H27N.CH4Cl2O6P2 |
| 163719-69-5 | Ethyl 3-(4-Chlorophenyl)-1,2,4-Oxadiazole-5-Carboxylate;acid ethyl ester;1,2,4-oxa<wbr>diazole-5<wbr>-carboxyl<wbr>ic acid, <wbr>3-(4-chlo<wbr>rophenyl)<wbr>, ethyl e<wbr>ster;3-(4-Chloro-phenyl)-[1,2,4]oxadiazole-5-carboxylic | C11H9ClN2O3 |
| 163719-70-8 | Ethyl 3-Isopropyl-1,2,4-Oxadiazole-5-Carboxylate;1,2,4-Oxa<wbr>diazole-5<wbr>-carboxyl<wbr>ic acid, <wbr>3-(1-meth<wbr>ylethyl)-<wbr>, ethyl e<wbr>ster;3-Isopropyl-[1,2,4]oxadiazole-5-carboxylic acid ethyl ester;3-Isopropyl-1,2,4-oxadiazole-5-carboxylate d'éthyle | C8H12N2O3 |
| 163719-72-0 | Ethyl 3-(4-Pyridinyl)-1,2,4-Oxadiazole-5-Carboxylate;4-Pyridin<wbr>-3-yl-[1,<wbr>2,4]oxadi<wbr>azole-5-c<wbr>arboxylic<wbr> acid eth<wbr>yl ester;Ethyl 3-(4-pyridinyl)-1,2,4-oxadiazole-5-carboxylate;ethyl 3-(4-pyridyl)-1,2,4-oxadiazole-5-carboxylate | C10H9N3O3 |
| 163719-76-4 | Ethyl 3-(2-Pyridinyl)-1,2,4-Oxadiazole-5-Carboxylate;1,2,4-oxa<wbr>diazole-5<wbr>-carboxyl<wbr>ic acid, <wbr>3-(2-pyri<wbr>dinyl), e<wbr>thyl ester;3-(Pyridi<wbr>n-2-yl)-1<wbr>,2,4-oxad<wbr>iazole-5-<wbr>carboxyli<wbr>c acid et<wbr>hyl ester;3-Pyridin<wbr>-2-yl-[1,<wbr>2,4]oxadi<wbr>azole-5-c<wbr>arboxylic<wbr> acid eth<wbr>yl ester | C10H9N3O3 |
| 163719-78-6 | 5-Ethenyl-1,2,4-oxadiazole-3-carboxylic acid ethyl ester | C7H8N2O3 |
| 163719-80-0 | Ethyl 3-(4-Pyridinyl)-1,2,4-Oxadiazole-5-Carboxylate;4-Pyridin<wbr>-3-yl-[1,<wbr>2,4]oxadi<wbr>azole-5-c<wbr>arboxylic<wbr> acid eth<wbr>yl ester;Ethyl 3-(4-pyridinyl)-1,2,4-oxadiazole-5-carboxylate;ethyl 3-(4-pyridyl)-1,2,4-oxadiazole-5-carboxylate | C10H9N3O3 |
| 163719-81-1 | Ethyl 3-(4-Fluorophenyl)-1,2,4-Oxadiazole-5-Carboxylate;1,2,4-oxa<wbr>diazole-5<wbr>-carboxyl<wbr>ic acid, <wbr>3-(4-fluo<wbr>rophenyl)<wbr>, ethyl e<wbr>ster;3-(4-Fluo<wbr>ro-phenyl<wbr>)-[1,2,4]<wbr>oxadiazol<wbr>e-5-carbo<wbr>xylic aci<wbr>d ethyl e<wbr>ster;3-(4-Fluo<wbr>rophenyl)<wbr>-1,2,4-ox<wbr>adiazole-<wbr>5-carboxy<wbr>lic acid <wbr>ethyl est<wbr>er | C11H9FN2O3 |
| 163725-12-0 | 2-[(2-Cyanophenyl)Sulfanyl]Benzoic Acid;2-(2-Cyanophenylthio)benzoic acid;2-(2-CYANOPHENYLTHIO)BENZOICACID;2-[(2-cyanophenyl)thio]benzoic acid | C14H9NO2S |
| 163733-96-8 | 3,4,5-Trifluoroaniline | C6H4F3N |
| 163733-99-1 | 4-Amino-2,3-difluorophenol | C6H5F2NO |
| 163734-01-8 | 2-Amino-4,5-difluorophenol | C6H5F2NO |
| 163759-49-7 | 2'-O-(2-Methoxyethyl)-5-methyluridine;1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | C13H20N2O7 |
| 163759-50-0 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-5-methyluridine;1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-(2-methoxyethoxy)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | C34H38N2O9 |
| 163759-94-2 | N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-5-methylcytidine 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] | C50H60N5O10P |
| 163759-97-5 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)uridine 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] | C42H53N4O10P |
| 163765-44-4 | (R)-4-Boc-2-methylpiperazine;(R)-1-Boc-3-methylpiperazine; tert-Butyl (R)-3-methyl-1-piperazinecarboxylate | C10H20N2O2 |
| 163768-50-1 | Auristatin F;(2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methylpropanoyl]amino]-3-phenylpropanoic acid | C40H67N5O8 |